Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Vascular endothelial growth factor-B (VEGF-B) is closely related to VEGF-A, an effector of blood vessel growth during development and disease and a strong candidate for angiogenic therapies. To further study the in vivo function of VEGF-B, we have generated Vegfb knockout mice (Vegfb(-/-)). Unlike Vegfa knockout mice, which die during embryogenesis, Vegfb(-/-) mice are healthy and fertile. Despite appearing overtly normal, Vegfb(-/-) hearts are reduced in size and display vascular dysfunction after coronary occlusion and impaired recovery from experimentally induced myocardial ischemia. These findings reveal a role for VEGF-B in the development or function of coronary vasculature and suggest potential clinical use in therapeutic angiogenesis.

Type

Journal article

Journal

Circ Res

Publication Date

04/02/2000

Volume

86

Pages

E29 - E35

Keywords

Aging, Animals, Animals, Newborn, Coronary Vessel Anomalies, Coronary Vessels, Endothelial Growth Factors, Female, Heart, Heart Defects, Congenital, Immunohistochemistry, Male, Mice, Mice, Knockout, Myocardial Ischemia, Myocardium, Vascular Endothelial Growth Factor B